Abstract
Plasmepsins, falcipains and aminopeptidases are Plasmodium falciparum proteases involved in human host hemoglobin degradation and other processes like erythrocyte invasion and rupture. Antimalarial drug resistance and natural selection in parasite are important reasons that create the urgent need of novel targets and lead compounds to overcome the burden of malaria. This report explored progress of the study covering proteases and their inhibitors specific to hemoglobin degradation. Additionally, in silico predicted antimalarial targets, balancing selection and drug-protein interaction are included.
Keywords: Hemoglobin degradation, plasmepsins, falcipains, drug targets, malaria, polymorphisms.
Current Drug Targets
Title:Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Volume: 16 Issue: 10
Author(s): Tabish Qidwai
Affiliation:
Keywords: Hemoglobin degradation, plasmepsins, falcipains, drug targets, malaria, polymorphisms.
Abstract: Plasmepsins, falcipains and aminopeptidases are Plasmodium falciparum proteases involved in human host hemoglobin degradation and other processes like erythrocyte invasion and rupture. Antimalarial drug resistance and natural selection in parasite are important reasons that create the urgent need of novel targets and lead compounds to overcome the burden of malaria. This report explored progress of the study covering proteases and their inhibitors specific to hemoglobin degradation. Additionally, in silico predicted antimalarial targets, balancing selection and drug-protein interaction are included.
Export Options
About this article
Cite this article as:
Qidwai Tabish, Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets, Current Drug Targets 2015; 16 (10) . https://dx.doi.org/10.2174/1389450116666150304104123
DOI https://dx.doi.org/10.2174/1389450116666150304104123 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dopamine and the Diseased Brain
CNS & Neurological Disorders - Drug Targets Anti-inflammatory Activity of PLA<sub>2</sub> Inhibitory Saccharumoside-B
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Validated, Stability Indicating HPTLC Method for the Determination of Mycophenolate Mofetil in Human Plasma
Current Analytical Chemistry Therapeutics Interventions with Anti-Inflammatory Creams in Post Radiation Acute Skin Reactions: A Systematic Review of Most Important Clinical Trials
Recent Patents on Inflammation & Allergy Drug Discovery Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology Targeting Tumorangiogenesis in Lung Cancer by Suppression of VEGF and its Receptor - Results from Clinical Trials and Novel Experimental Approaches
Current Medicinal Chemistry CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Immunomodulatory Effects of Agarwood Leaf Extract on RAW264.7 Murine Macrophages
Endocrine, Metabolic & Immune Disorders - Drug Targets Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Expression, Purification and Auto-Activation of Cathepsin E from Insect Cells
Protein & Peptide Letters Extra Virgin Olive Oils Polyphenols: Biological Activities
Current Pharmaceutical Design Low Concentration of Caffeine Inhibits the Progression of the Hepatocellular Carcinoma <i>via Akt</i> Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Erratum
Current Pharmaceutical Design Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
Current Neuropharmacology The Peripheral Anionic Site of Acetylcholinesterase: Structure, Functions and Potential Role in Rational Drug Design
Current Pharmaceutical Design Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials
Current Topics in Medicinal Chemistry Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry